Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hydroxyl chalcone derivative DK02 as a multi-target-directed ligand for Alzheimer's disease: A preclinical study in zebrafish.
Haridevamuthu B, Bharti AK, Nayak SPRR, Narayanan D, Loganathan Sumathi D, Chagaleti BK, Saravanan V, Rajagopal R, Alfarhan A, Muthu Kumaradoss K, Arockiaraj J. Haridevamuthu B, et al. Among authors: muthu kumaradoss k. Br J Pharmacol. 2024 Dec 22. doi: 10.1111/bph.17426. Online ahead of print. Br J Pharmacol. 2024. PMID: 39710579
Protective effect of a novel furan hybrid chalcone against bisphenol A-induced craniofacial developmental toxicity in zebrafish embryos.
Haridevamuthu B, Madesh S, Bharti AK, Dhivya LS, Rajagopal R, Alfarhan A, Muthu Kumaradoss K, Arockiaraj J. Haridevamuthu B, et al. Among authors: muthu kumaradoss k. Comp Biochem Physiol C Toxicol Pharmacol. 2025 Feb;288:110072. doi: 10.1016/j.cbpc.2024.110072. Epub 2024 Nov 19. Comp Biochem Physiol C Toxicol Pharmacol. 2025. PMID: 39571873
COX-2 targeted therapy for diabetic foot ulcers using T7-enhanced CS-PVA membranes.
Murugan R, Ashok K, Ramya Ranjan Nayak SP, Deivasigamani P, Almutairi MH, Almutairi BO, Guru A, Muthu Kumaradoss K, Arockiaraj J. Murugan R, et al. Among authors: muthu kumaradoss k. Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113206. doi: 10.1016/j.intimp.2024.113206. Epub 2024 Sep 30. Int Immunopharmacol. 2024. PMID: 39353389
Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation - A systematic computational approach to discover novel cancer therapeutics.
Chagaleti BK, B SK, G V A, Rajagopal R, Alfarhan A, Arockiaraj J, Muthu Kumaradoss K, Karthick Raja Namasivayam S. Chagaleti BK, et al. Among authors: muthu kumaradoss k. Comput Biol Chem. 2024 Oct;112:108134. doi: 10.1016/j.compbiolchem.2024.108134. Epub 2024 Jun 25. Comput Biol Chem. 2024. PMID: 38964206 Review.
Discovery and development of COVID-19 vaccine from laboratory to clinic.
Saravanan V, Chagaleti BK, Narayanan PL, Anandan VB, Manoharan H, Anjana GV, Peraman R, Namasivayam SKR, Kavisri M, Arockiaraj J, Muthu Kumaradoss K, Moovendhan M. Saravanan V, et al. Among authors: muthu kumaradoss k. Chem Biol Drug Des. 2024 Jan;103(1):e14383. doi: 10.1111/cbdd.14383. Epub 2023 Nov 13. Chem Biol Drug Des. 2024. PMID: 37953736 Review.